The Morehouse School Of Medicine, Inc.

The Morehouse School of Medicine, Inc., doing business as Morehouse School of Medicine, is a private, non-profit historically black college and university (HBCU) based in Atlanta, Georgia, that acts as a federal grant recipient and prime contractor, delivering medical education, biomedical research, healthcare workforce training, and specialized scientific investigation services to federal agencies on both a prime and sub-recipient basis. MSM is a tax-exempt corporate entity with no SBA set-aside designations; it competes on a full-and-open basis across civilian health and research funding streams.

MSM's federal footprint is dominated by research and education grants rather than contracts. The institution received 557 total federal awards (prime and sub combined) in recent years, with combined potential value of $13.1 million, though obligated dollars across all awards total $1.4 billion—reflecting the institution's role as a long-standing grant recipient managing multi-year federal funding commitments. MSM operates as a prime on 76% of awards (426 awards) and as a sub-recipient on 24% (131 awards), with activity concentrated in fiscal 2024 (65 awards) and 2025 (42 awards).

Customer concentration is distributed across federal research and health agencies rather than concentrated with a single customer. The Department of Health and Human Services National Institutes of Health dominates by award count (81 awards including 35 from the National Institute of General Medical Sciences), followed by the Health Resources and Services Administration (37 awards) and the Department of the Navy Bureau of Medicine and Surgery (33 awards, $2.1 million combined potential value). The Navy provides the largest dollar concentration on the potential-value side, anchored by a Basic Ordering Agreement (N0014098G2490) with the Bureau of Medicine and Surgery established April 15, 2026, with a ten-year term through April 2036, which supports tuition, fees, medical education, biomedical research, healthcare training, and specialized scientific investigation. Recent Navy delivery orders cover fall 2025 tuition and fees ($144,661.79) and spring 2025 tuition and fees ($75,426.50).

MSM's grant portfolio spans research, workforce development, and infrastructure investment. Representative prime grant work includes a $702,086 project grant from the National Institute for Minority Health and Health Disparities (CFDA 93.307) awarded August 2026 to adapt the Diabetes Prevention Program for family engagement and health history assessment in populations at elevated type 2 diabetes risk; a $7.39 million project grant from the National Science Foundation Division of Human Resource Development (CFDA 47.076) awarded September 2025 to establish a Centers for Research Excellence in Science and Technology (CREST) phase-one center focused on circadian rhythmicity and sleep homeostasis; and a $2.283 million project grant from the National Institute on Aging (CFDA 93.866) awarded September 2024 to develop and validate a progressive mouse model for traumatic brain injury-related Alzheimer's disease and related dementias. MSM also operates as a sub-recipient on grants anchored by Emory University (the most frequently named prime grantee across the sub-award footprint), the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center, and other regional research institutions, delivering workforce training, research participation, and community engagement on initiatives spanning diabetes equity research, clinical translational science, maternal and child health, and infectious disease research.

MSM's subcontractor engagement under federal contracts is minimal. Service Contract Inventory captures only 2 SCI-reportable records (both as named subcontractor in FY2022), reflecting roughly 0.5 FTEs. The institution's contract activity runs primarily through the Navy Basic Ordering Agreement and associated delivery orders for educational tuition and fees; these are firm fixed-price, full-and-open awards with no set-aside designation. MSM functions predominantly as a grant-funded education and research institution rather than as a contract services vendor, and when it does subcontract on federal work, it does so in a sub-recipient or subcontractor role on research collaboratives led by larger research universities.

The recompete landscape includes 26 awards with ultimate completion dates within the next twenty-four months, representing a modest recompete exposure relative to the institution's large multi-year grant portfolio. MSM's federal strategy centers on federal grant and cooperative agreement funding from the National Institutes of Health, HRSA, and the National Science Foundation, focused on health disparities, minority health research, and STEM workforce development aligned with its HBCU mission.